Hydroxycarbamid Labatec 500 mg, capsules

7680661310033 CH-66131 Kapseln
Hydroxycarbamid Labatec 500 mg, capsules
Hydroxycarbamid Labatec 500 mg, capsules
Hydroxycarbamid Labatec 500 mg, capsules
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/04/2025
Patient information leaflet
Français
02/04/2025
Patient information leaflet
Italien
02/04/2025
Summary of Product Characteristics
Allemand
02/04/2025
Summary of Product Characteristics
Français
02/04/2025
Summary of Product Characteristics
Italien
02/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
41.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
6.6 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 81.05
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2019

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
66131
Drug name
Hydroxycarbamid Labatec, capsules
Galenic form
KAHA
ATC Code
L01XX05
Authorization status
Z
Dispensing category
A
First authorization
30/06/2016
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
HYDROXYCARBAMID Labatec caps 500 mg 100 pce
Description (DE)
HYDROXYCARBAMID Labatec Kaps 500 mg 100 Stk
Market launch
30/06/2016
Narcotic (BTM)
No

Original drug

Litalir, Hartkapseln
GTIN: 7680529580165
CHF 87.15
View original

Other package sizes (2)

None
30 KAP
GTIN: None
Not in V1
HYDROXYCARBAMID Labatec caps 500 mg 50 pce
50 KAP
GTIN: 7680661310026
View